GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHF) » Definitions » 3-Year FCF Growth Rate

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) 3-Year FCF Growth Rate : -24.40% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Aspen Pharmacare Holdings 3-Year FCF Growth Rate?

Aspen Pharmacare Holdings's Free Cash Flow per Share for the six months ended in Dec. 2023 was $-0.05.

During the past 12 months, Aspen Pharmacare Holdings's average Free Cash Flow per Share Growth Rate was -48.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Aspen Pharmacare Holdings was 131.20% per year. The lowest was -40.60% per year. And the median was 8.45% per year.


Competitive Comparison of Aspen Pharmacare Holdings's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's 3-Year FCF Growth Rate falls into.



Aspen Pharmacare Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Aspen Pharmacare Holdings  (OTCPK:APNHF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Aspen Pharmacare Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Traded in Other Exchanges
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos 03-17-2019